The European Commission (EC) has approved Celltrion’s Avtozma (CT-P47), a biosimilar referencing Roche’s RoActemra (tocilizumab). https://t.co/ukMDwtgUhw https://t.co/htDVWKbu3n
Links:
EC approves Celltrion’s RoActemra biosimilar Avtozma for inflammatory diseases …
https://buff.ly/6Gbmadd
Mar-12-2025
